This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk05: Greetings and welcome to the Maximus Fiscal 2021 First Quarter Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Lisa Miles, Senior Vice President of Investor Relations for Maximus. Thank you, Ms. Miles. You may begin.
spk04: Good morning, and thank you for joining us today. With me is Bruce Caswell, President and Chief Executive Officer, and Rigne Doe, Chief Financial Officer. I'd like to remind everyone that a number of statements being made today will be for looking in nature. Please remember that such statements are only predictions. Actual events and results may differ materially as a result of the risks we face, including those discussed in item 1A of our annual report on Form 10-K. We encourage you to review the information contained in our earnings release today and our most recent forms, 10Q and 10K, filed with the SEC. The company does not assume any obligation to revise or update these forward-looking statements to reflect subsequent events or circumstances, except as required by law. Today's presentation may contain non-GAAP financial information. Management uses this information in its internal analyses of results and believes this information may be informative to investors in gauging the quality of our financial performance, identifying trends in our results, and providing meaningful period-to-period comparisons. For a reconciliation of the non-GAAP measures presented in this document, please see the company's most recent quarterly earnings press release. And with that, I'll hand the call over to Rick.
spk03: Thank you, Lisa. This morning Maximus reported revenue for the first quarter of fiscal 2021, which increased 15.6% to $945.6 million. Revenue for the first quarter was in line with our expectations. Our revenue growth was principally driven by new work related to the COVID pandemic response, where Maximus continues to play an integral role in contact tracing, disease investigation, vaccination support, unemployment insurance programs, and other key initiatives. For the first quarter of fiscal 2021, our COVID response work contributed approximately $160 million in revenue. As expected, top and bottom line growth were offset by ongoing impacts of the global pandemic tied to program changes on volume-based contracts that were implemented at the direction of our customers. As we discussed last quarter, these changes, including halting Medicaid redeterminations in the United States, are designed to ensure that beneficiaries have uninterrupted access to vital government benefits during this global health crisis. Total company operating margin was 9.3% for the first quarter of fiscal 2021. Divided earnings per share were $1.03 per share. Both operating margin and earnings were in line with our expectations with some variability by segment. Our operations outside the United States delivered results favorable to our expectations, which offset lower operating income from the U.S. federal segment due to the timing of finalizing a contract, which will now be recorded in the second quarter. Let me review segment financial results in our typical order, starting with U.S. services. First quarter revenue in the U.S. services segment increased 23.3% to $384.9 million. While revenue growth was driven by an estimated $114 million of COVID response work, the operating margin was depressed by temporary program changes and lower revenue from performance-based contracts as a result of the global pandemic. Operating margin for the U.S. services segment was 16% for the first quarter. As discussed last quarter, we continue to experience a significant revenue and profit headwind resulting from lower volumes on some of our largest Medicaid programs. As a reminder, many state customers are currently utilizing enhanced U.S. federal matching funds for Medicaid. However, they must adhere to certain conditions including a pause in Medicaid redeterminations to ensure beneficiaries have continued access to vital healthcare services during the global public health crisis. Those redeterminations are a significant level of activity within certain programs we operate. Our full year expectations for the U.S. services segment remain unchanged with a 16.5 to 17.5% full year margin predicted. Revenue for the first quarter of fiscal 2021 for the U.S. federal services segment increased 10.6% to $405.2 million. The census contract contributed $60 million, which was $10 million less than the prior year. Excluding the census contract, organic growth for this segment was 13.5% and driven principally by an estimated $46 million of revenue from COVID response work as we continue to provide needed support to government in responding to the pandemic. This includes work with the IRS supporting the CARES Act, which, as a reminder, is the first time the IRS has used contracted agents on this large of a scale. The U.S. Federal Services segment had approximately $4 million of revenue and profit shift out of the first quarter due to a delay in executing a contract. It has been signed, and we will record the benefit in the second quarter of fiscal 2021. The operating margin was 7.5%, which was slightly short of our expectations for a strong first quarter in this segment. Our full-year expectations for the U.S. Federal Services segment remain the same, with a 6% to 7% full-year margin predicted. Looking to the second quarter, including the aforementioned $4 million of revenue and profit we will recognize, the segment's margin is expected to step down. This illustrates how we continue to have more overall variability in results due to the pandemic. We are pleased to have secured COVID response work to backfill some of the temporary shortfalls created by reduced volumes, revenue, and profit from accretive performance-based contracts. Revenue for the first quarter of fiscal 2021 for the outside the U.S. segment increased 11.5% to $155.4 million. Organic growth excluding the effects of currency, was 4.8%. Operating income for the segment in the first quarter of fiscal 2021 was positive $4.5 million for an operating margin of 2.9%. The better than expected result for the quarter was primarily due to job placement activities in Australia, driven by a seasonal spike in demand for qualified job seekers. As Australia started to emerge from the pandemic during our first quarter, employers needed to quickly fill many retail and travel-related jobs during the busy holiday and travel season. The Australian team did an extraordinary job in successfully managing this influx of demand, but we view this seasonal spike as unique to the first quarter of fiscal 2021. We continue to see strong demand for employment services in all of our international operations. We have had positive developments since our last earnings call related to increasing demand and rising volumes for employment services. We anticipate that volumes from current programs, most notably in Australia, and supplemented by new work, will drive revenue growth in the second half of fiscal 2021. It is important to note that the new work consists of outcomes-based arrangements for employment services. They are designed to ensure that contractors can be held accountable and incentivized to achieve the job placement and retention outcomes that matter to government. This new employment services work drives our revenue estimates upward, but these programs are expected to generate losses in their early stages. However, we target operating margins within our desired corporate average over the life of such programs. We presently estimate that these startups will put the outside the U.S. segment in a lost position in the second quarter, with steady improvement through the remainder of the year. We now expect that the segment will be approximately break-even for fiscal 2021. Maximus enjoys a long history, strong reputation, and demonstrated success in delivering employment services. We believe the investment required will position us for favorable economics over the life of the contracts, which outweighs the temporary adverse impact in profit for the remainder of fiscal 2021. We believe such programs are a good avenue to create substantial long-term shareholder value. Let me turn to cash flow items and the balance sheet. We had no draws on our corporate credit facility at December 31, 2020, and $132.6 million of cash and cash equivalents. Cash from operations and free cash flow of $98.1 million and $89 million, respectively, were strong and contributed to our already strong balance sheet. DSO was 75 days at December 31, 2020, compared to 77 days at September 30, 2020. Let me touch briefly on capital allocation. While we generally operate under an essential provider designation, we remain aware of budget pressures impacting our customers. However, with our corporate credit facility and the aforementioned strong cash flows and balance sheet, liquidity is not a concern. We continue to have a bias toward M&A as a means to drive long-term organic growth. Our M&A program continues to evaluate prospects while we remain prudent stewards of capital and selective in our evaluations. Our strong balance sheet and good cash from operations provides us good access to capital to fund acquisitions. We remain committed to future quarterly cash dividends, and share purchases will continue to be made opportunistically. While it is still early in the year, recent award scope increases and contract extensions have provided us with cautious optimism as we consider our full-year guidance. As a result of these positive developments, we are raising our full-year guidance for fiscal 2021. For the full year, we expect revenue will now range between $3.4 billion and $3.525 billion for fiscal 2021, driven by new work in support of government's ongoing response to COVID. Additionally, we expect diluted earnings per share will range between $3.55 and $3.75 for fiscal 2021. Our fiscal 2021 cash from operations are projected to now be between $350 million and $400 million, and free cash flow between $310 million and $360 million. Our expectations for our effective income tax rate is between 25.75% and 26.5%, and for weighted average shares to be between $62.1 million and $62.2 million. As we have long said, we often experience fluctuations in our quarterly financial results. which has only been exacerbated by the pandemic. However, the management team aims to provide as much transparency into our work as reasonably possible. So based on what we know today, we still expect a decrease in revenue and earnings for the second quarter of fiscal 2021 compared to the first quarter. Current second quarter consensus estimates show revenue of $773 million and diluted earnings per share of 73 cents. At the present time, we expect to be above consensus revenue and earnings estimates for the second quarter. Consequently, fourth quarter consensus revenue of $875 million and daily returns per share of $1.02 are above our current expectations. While the new COVID response work is providing a short-term positive tailwind, it has shorter periods of performance than our core contracts. As we have cautioned previously, there is no assurance that the tailing off of the positive impacts of the COVID response work will coincide with the return of our core contracts to previous volume and performance levels. Our bottom line continues to be somewhat tempered by unfavorable headwinds related to the pandemic and the temporary changes on mature core programs, most notably in the United States and United Kingdom. The result has been a reduction in accretive revenue, which continues to temper operating income margins and diluted earnings per share. We anticipate that as we emerge from the pandemic, many of these programs will begin to return to historical volume levels. Factors such as the end of the public health emergency declaration in the United States and when we resume face-to-face assessments in the United Kingdom are particularly important to the pattern of expected recovery. The effects of budget challenges, further relief packages, and other changes in policies or legislation are some, but not necessarily all factors that can impact our assumptions for fiscal 2021 and beyond. I would like to end by saying that Bruce and I are proud of the team at Maximus for remaining on track to deliver solid performance this fiscal year. Following the outbreak of COVID, there were many unknowns that we had to work through. Unknowns remain. We are not free from the impacts of the pandemic. but we have a solid footing which gave us the confidence to raise guidance. And with that, I will turn the call over to Bruce. Thank you, Rick, and good morning, everyone. Last month, Maximus announced the planned retirement of our friend and trusted colleague, Rick Nadeau. While we still have a few more earnings calls before his departure, I wanted to say that it has been an absolute privilege to work alongside Rick for these many years. And I wanted to thank him for his endless commitment and invaluable contributions during his time at Maximus. David Mutrin, Senior Vice President of Finance, will assume the role of CFO effective December 1st, 2021. I look forward to working with both Rick and David over the next nine months as we continue to execute our corporate strategy. With the election of President Biden, we're cautiously optimistic regarding the stated policy initiatives from the administration and the potential favorable tailwinds that may be created for companies like Maximus. The administration has already taken actions to increase access to affordable insurance for Americans through the Affordable Care Act and Medicaid. Over the course of the administration, we will likely see a meaningful increase in funding for social welfare programs and, of course, public health programs. Improving access to affordable health care is a top priority of the Biden administration, and the President has advocated building upon the Affordable Care Act, among other measures, to broaden coverage options for Americans. Additionally, as we navigate through the pandemic, we believe we will see further policy initiatives that strengthen the public health infrastructure and a corresponding effort to more broadly support vulnerable populations. President Biden has already expressed intent to tackle these challenges, and indeed many of his early executive orders look to expand the public health workforce to provide vital services to individuals. Our results this morning illustrate that Maximus is well positioned to help government add capacity and address critical public health needs now and into the future. While it's still early days in the Biden administration, we're cautiously optimistic that the areas we have seen emphasized thus far will be reflected in subsequent budget and legislative priorities that set the stage for capitalizing on opportunities to partner with government in helping to achieve their policy initiatives. Our COVID response work is a prime example of the demonstrated value of our services and the relationships we've developed with our clients. In a time of unprecedented challenges, we are grateful to have earned the opportunity to provide needed assistance. These contracts have served as a revenue driver, offsetting some of the unfavorable impacts on operations that are experiencing a pandemic-related temporary slowdown or pause. Initially, our COVID work centered around more immediate pandemic-driven needs such as contact tracing, disease investigation, and unemployment insurance programs. Our work has expanded as government demand has increased into new areas. We launched efforts to support states in responding to public questions about vaccination registration, scheduling, and administration quickly, efficiently, and equitably. We have hired several thousand employees to support these state and local efforts. At the federal level, as you know, we also operate the CDC helpline known as CDC Info, We recently added another 150 individuals as we scale up our operations yet again to answer questions regarding vaccinations. Supporting several states and the CDC, we are the most experienced government partner in the market to provide vaccine administration citizen services. Additionally, our U.S. federal services segment scaled up to 3,200 agents from 1,500 to support the IRS with the next round of the economic incentive payments. Further, in order to improve the user experience and drive efficiency, we implemented our interactive virtual agent system in response to the increased demand. As Rick noted, we're also experiencing increased demand for our employment support services around the globe. The economic impacts of the global pandemic have left many unemployed and in need of vital support and finding work. It's important to remember that the pace at which different countries are emerging from the pandemic varies widely. Some countries have progressed further in managing the spread of the pandemic and are now turning their attention to tackling the many residual challenges, including the economy and unemployment. Maximus has a proven track record in delivering employment services and an earned reputation as a trusted long term partner who delivers outcomes that matter. Our continued investments support our position as a partner of choice over the long term, outweighing any temporary and short-term profit impacts in fiscal year 2021. While the COVID work itself is comparatively short-term in nature, crisis support itself has a longer trajectory. While this pandemic was certainly unprecedented, this is not our first nor our last call to action in a time of public health or economic crisis. We will continue to be there to support our clients and citizens in times of need with critical services and solutions. Our work is portable, adaptable from agency to agency and department to department, whether it's the IRS, CDC, FEMA, state health departments, or others around the world. We adapt from crisis to crisis, whether a global health pandemic, a natural disaster, or economic challenges. Along with the launch of Maximus Public Health, we view our capabilities in contingency planning for our government customers and the rapid implementation of citizen assistance services as a core competency and elemental to the long-term relationships that underpin our business. Looking outside of the pandemic, I've previously talked about our solutions that are authorized under the Federal Risk and Authorization Management Program, or FEDRAMP. Our FedRAMP certifications meet the most stringent security requirements of federal agencies as we aim to deliver innovative and cost-effective cloud-based solutions that support mission objectives and provide the highest quality citizen services, thereby transforming the user experience. We fielded a survey of government technology leaders across federal, state, and local agencies to gain insights about where agencies are in their cloud adoption journey. and how they perceive the use of FedRAMP-authorized cloud solutions to support their modernization and transformation initiatives. The vast majority of respondents recognized benefits from moving to a FedRAMP-authorized solution beyond adhering to mandates. This survey further affirmed our solid positioning to provide a range of FedRAMP-secure cloud solutions, as well as our clients' demand for this service. I will now turn to new awards and pipeline as of December 31st. For the first quarter of fiscal 2021, signed awards were $594 million of total contract value at December 31. Further, at December 31, there were another $1.14 billion worth of contracts that had been awarded but not yet signed. Let's turn our attention to our pipeline of addressable sales opportunities. Our total contract value pipeline at December 31st was $31.6 billion compared to $33.0 billion reported in the fourth quarter of fiscal 2020. Of our total pipeline of sales opportunities, 71.1% represents new work. I want to reiterate the continued difficulty in predicting the impact that the global health pandemic may have on our pipeline, timing of new work, and return to previous operational levels. However, our strong reputation flexibility and agility has cemented our position as a go-to partner for government we have navigated administration transitions for decades and we firmly believe that the foundation is laid for continued opportunities to assist governments through these extraordinary times i wanted to wrap up my comments today reflecting on the events and protests that occurred in january at the u.s capital in washington d.c and in other areas of the country Like many of you, I was shocked and saddened by these events. Maximus engages in the bipartisan political process in order to better understand our government clients' long-term goals. Our board's Nominating and Governance Committee has oversight of the company's policies pertaining to political contributions and compliance. We remain committed to the fundamental principle of our engagement in the political process, which is and will continue to be to never support or fund candidates or elected officials who encourage or support violence against the government of the United States. And one final note before we open it up for questions. The macro trends for our business remain unchanged. As the pandemic has underscored, governments around the world need better solutions to deliver on policy priorities that can change rapidly. Social welfare programs that reflect long-term societal commitments and priorities increasingly face rising demand, shifting demographics, and unsustainable program costs. Maximus is well positioned to address these challenges and be a transformative partner. We offer scalable, cost-effective, and operationally efficient services for a wide range of government programs. We continue to believe our portfolio mix of core business, near adjacencies, and new growth platforms will allow us to achieve a healthy growth trajectory for years to come. And with that, we will open the line for Q&A. Operator?
spk05: Thank you. We will now be conducting a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. A confirmation tone will indicate that your line is in the question queue. You may press star 2 if you would like to remove your question from the queue. We ask that you limit your follow-up questions to one so that others may have an opportunity to ask questions. You may re-enter the queue by pressing star one. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment, please, while we poll for questions. Thank you. Our first question is from Brendan Popsin with CJS Securities. Please proceed with your question.
spk00: Good morning. I just want to ask real quick on the draft is out on the CCO, sorry, the draft RFP for 1-HR Medicare, and just any surprises there or any thoughts on that?
spk03: Hey, Brendan, it's Bruce. Good morning and thanks for the question. Yes, we're pleased to see that that procurement is progressing, you know, really per schedule and to see the RFP out. And I would just offer you two notes. One is the scope of services that's reflected in the RFP is consistent with the current scope of services and work that we do for CMS. And secondly, it remains a single award procurement, which we think is a reflection of the comfort that CMS has had in administering the contract with a single vendor and their intent to do so going forward. Any other questions?
spk00: Great, thank you. Yeah, just a follow-up. You talked about some in the prepared comments with the new administration coming in, but could you provide any more color or detail on the impact of recent executive orders in the new administration and any new opportunities or even just expanded opportunities on what you currently do?
spk03: Sure, Brendan. Let me give you a little more color. Interestingly, there was an executive order that obviously was created very early in the process here to reopen healthcare.gov for what's known as a special enrollment period, or SEP, and that will take place between February 14th and May 15th. As you likely know, individuals can already purchase policies at healthcare.gov outside of the open enrollment period when they have certain qualifying life events. But this special enrollment period is adjacent now to a just-ended open enrollment period, and it seeks to provide access to individuals who would otherwise not qualify with qualifying life events during this time. Because of its proximity to the recently ended open enrollment period, the pool of potential enrollees is likely smaller than if it were to have occurred later. However, that means it'll be really the uptake will be a function of outreach and advertising and awareness efforts. And we note that HHS is committing $50 million to such efforts. As I was reading a bit more about this, the Kaiser Family Foundation estimates that nearly 9 million of the remaining uninsured Americans could qualify for free or subsidized coverage under this special normal period. And there's an additional 6 million that could qualify for unsubsidized coverage. So, again, marketing and advertising is going to be critical. From a state perspective, state-based marketplaces, and I make this note because, as you're aware, we have the privilege of providing call center support for the federal marketplace and the states that remain on that, also for a number of state customers. States are encouraged but not required to offer similar special enrollment periods, and many are going ahead and doing that. So what does it mean for Maximus? We think that given all of these dynamics, the guidance range that we've established that Rick spoke to in his prepared remarks likely covers the potential tailwinds that could be created from the executive orders. And, obviously, the effects of efforts to increase marketing and advertising and so forth will go well beyond the May end date of this special enrollment period and likely would manifest themselves in higher volumes of enrollment in the next open enrollment period in the fall. Hope that helps.
spk00: Hey, Greg, thank you for the detail. Appreciate it.
spk05: Thanks, Brandon. Next question, please. Our next question is with Richard Close from Canaccord Genuity. Please proceed with your question.
spk01: Great. Can you hear me okay, first of all? Just fine, Richard. Hope you're doing well. I am. Thank you. Rick, congratulations. Looking forward to the next couple quarters with you, or three quarters. But congratulations on the retirement. Thank you. yeah so rick first just a quick um housekeeping and i appreciate the information with respect to the census um and covid um but you know the 13.5 percent organic growth in federal um unless i'm doing the math wrong if i back out the 60 million per census this year and the 70 million for last year i'm getting like a 16.4 percent um organic growth um number not taking into account the covid but am i missing something there is there an acquisition an acquisition or something else uh that you're backing out to get to the 13.5 um yes
spk03: Good question. Yes, we're backing out the effects of that CQA contract. That's about 4.4%. The organic growth from other contracts is 12.5%, and the disposal of the businesses is 0.4%. So all of that together is a 16.5% change. Okay. then and we're going to spot we're going to follow our form 10q right after this call and and those calculations are in the mdna we actually do a roll forward from the and we do it by segment we do a roll forward of the three months uh revenue ended december 31 2019 to three months ended December 31, 2020. And we'll show you the effect of the CQA contract, which I think you're basically right. It was 1670, so about a reduction of $9.6 million. And then the amount of the disposal of the business. That's a business that we had a potential conflict of interest or a perceived conflict of interest with other work that we were bidding and we were asked to dispose of it with the rest of it being organic.
spk01: Okay, great. I just figured there were some other moving parts in there. Bruce, I wanted to talk a little bit about the redeterminations. Obviously, Secretary Azar extended the public emergency, I think, into April. I'm not sure the specific date. There, but then there was also speculation from the Biden administration. I think there was a letter sent to some individuals about maybe extending the public health emergency program. um through 2021 um so i i'm curious your thoughts on redeterminations whether um if the emergency does get extended um you know are there opportunities that the you know states they're getting the f map um but is there opportunities where redeterminations begin or would they be extended all the way into 2022?
spk03: So, Richard, I'm going to pick that up in just a second, but first I wanted to return to Rick so he could clarify something from your prior question and then we'll look at that. Okay. Yeah, Richard, I think I read the percentage from the wrong column. I read the revenue correctly. But what it is is we went from $366,571 of revenue to $405,245 for 2020. CQA contract did go down $9.6 million, and the disposal went down 1.1. That gives you an organic growth of 49.4%. That's 13.5%, 49.4 million. So that gives you 13.5%. That's a clarification off that. I'm sorry. I was reading the gross profit. I read you the correct numbers on the dollars, and I read the percentages from the gross profit. My apologies. Maybe I'm getting a little... I don't know. Pull that forward. the wisdom's priceless so let me go to the public health emergency uh you're absolutely right um acting secretary of health and human services norris cochran uh sent a letter to governors on january 22nd and it's easy to find um and i'll quote from it saying to assure you of our commitment to the ongoing uh response we've determined that the public health emergency will likely remain in place through the entirety of 2021. When a decision is made to terminate the declaration or let it expire, HHS will provide states with 60 days notice prior to termination. So based on that, you know, it seems like the handwriting is on the wall. At the same time, as you know, we need to continue to work with our customers to get their guidance too. Because on the one hand, this would lead to likely further suspension of certain work, such as eligibility, redeterminations, and so forth. But on the other hand, the prolonged conditions that would unfortunately cause the sustainment of the public health emergency, thereby enabling states to qualify, as you've also noted, for the 6.2% enhanced FMAP, would suggest that at least certain COVID-related response work would continue well through the end of the current fiscal year. So given all of these considerations, when Rick and I looked at our guidance range, we felt that it's wide enough to accommodate multiple scenarios. And a public health emergency, to be clear, remaining in place for the entirety of fiscal year 2021 would likely result with us being a bit more in the middle of the fairway. So we always say it's kind of hard to predict COVID work. And interestingly, some of the temporary headwinds and program changes that we've seen relate to the public health emergency. For example, the pause in redeterminations is clearly linked to the maintenance of effort requirement for Medicaid to ensure individuals remain enrolled. And that's a qualification requirement for the enhanced funding. So unlikely, right, that states would, unless they're willing to give up that enhanced funding, you know, begin redeterminations or other, you know, kind of program administrative actions, you know, prematurely. However, there are other, you know, programs that we administer, for example, the Debt Management Program for Federal Student Aid or outside the U.S., the Haas Program, that aren't linked to this public health emergency so our guidance kind of accommodates all of those last thing i'd say is that the secretary retains a great deal of discretion not just in the declaration of the public health emergency and when it's over but also discretion to selectively modify the terms of it to reflect conditions and policy priorities as they evolve so All I can tell you right now is that we feel the guidance range we provided, you know, accommodates the variability, and we'll take guidance from our customers and respond to the conditions, you know, that they dictate for the administration and programs.
spk01: Okay, thank you. I appreciate everything you're doing for the states and federal government during this time. Thanks. Yeah, thank you.
spk04: Thanks, Richard. Next question, please.
spk05: As a reminder, if you would like to ask a question, please press star 1 on your telephone keypad. Our next question is from Donald Hooker with KeyBank Capital Markets. Please proceed with your question.
spk02: Thank you. Good morning, everyone. So I was curious. On your slide seven, you guys commented and highlighted that you think you can get to kind of a 10% to 15% operating margin, which is obviously a ton of upside in that out-of-the-U.S. segment. Can you time scope that a bit? Just remind us kind of when would that margin potentially be achieved?
spk03: Thanks, Donald. It's Bruce. And I do want to note that the commentary on Stage 7, I'll begin and then I'll hand it off to Rick. The commentary about the 10% to 15% margin is over a program's life, and the illustrative program is employment services programs, right? So you have to consider the portfolio of contracts that we have outside the U.S. as you think about the long-term margin dynamics for that business. But I'll let Rick offer the commentary. Sure. Thanks. Yeah, exactly what Bruce said. And I think the simple chart on that page tells the story. When we go through and we are considering how to bid a program, you know, we have to respond to the request for proposal that's sitting in front of us. And what really winds up happening in most cases is that the costs that you incur are relatively flat over time, but you build volumes throughout the program's life. And so accordingly, what winds up happening is that your costs are steady, but your revenue grows over time. So in the early parts of the program, you have negative operating income, and you can see the area under the straight line shows you a negative OI for the first periods of the program, and then that builds. And so what we do is we try to make sure that when we price the work, that when we put all of the periods together, that we're having an operating income margin that's in the 10% to 15% range, which is the average that we seek for the work that we bid that is fixed price type of work. Did that help you?
spk02: Yeah, I guess I was trying to put you a little bit on the spot in terms of you guys. I understand it's not the entirety of the outside of the U.S. segment, but you guys are talking about a break-even margin in the outside of the U.S. segment, and then you talk about a 10% to 15% margin for this. these employment contracts, which are, which is a big part of the outside of the segment. And would that be like fiscal 22 or fiscal 23? I mean, what is the, I don't know if you can sort of time scope that. It would take a couple of years to get there. I mean, that is a, that is a big jump in operating margin, even if it's not all of the segment, it would certainly have a material impact. And again, not seeing if I could get any clarity around how quickly I could ramp.
spk03: Well, yeah, I think that it's pretty obvious that the outside the U.S. segment is the segment that's been most damaged during the pandemic. We've had over 50 percent of the work that we do outside the U.S. is on employment services and closed economies in Australia and the United Kingdom have been very detrimental to us in that regard. So I think that when we look forward and come out of FY21 and look into FY22, it will obviously be somewhat dependent on the pandemic. You know, we have a big program in the United Kingdom where we were scheduled to do 780,000 face-to-face assessments in this last contract period, and we're doing none. You know, that Haas contract is profitable, but not at the level that we would have projected if we were doing those face-to-face assessments. So I think that the return to open economies in Australia and the United Kingdom, some of the new geographies that we're working on with employment services, a return to normality in the United Kingdom, allowing us to do those face-to-face assessments, and those new contracts that we talked about are all tailwinds that ought to be able to allow us to improve the operating margin outside the U.S. over time. I can't sit here today and promise you what that's going to be in FY22, but it will be an improving OI margin profile over time.
spk02: Okay. I'm not sure if I get to put my follow-up or not, but maybe I'll go ahead. You guys detailed the census revenues in the fiscal first quarter of the December quarter. What Can you remind us, and I apologize that I missed this, what would that round down to in the March, June, and September quarters? So, yeah, sort of set expectations.
spk03: Yeah. That program is very close to being over. It's in a heavy wind-down period. I think you're going to see less than $10 million of revenue going forward from January 1st, 2021 forward. Thank you.
spk02: Thank you. Good luck with everything. Thank you. Thank you.
spk04: Thanks, Donald. All right. Next question, please.
spk05: As a reminder, if you would like to ask a question, please press star 1 on your telephone keypad. We have reached the end of our question and answer session. and are out of time for today's call. Maximus thanks you for your time and participation. You may disconnect your lines at this time.
Disclaimer